Status:
WITHDRAWN
Patient Reported Outcomes in Pulmonary Arterial Hypertension
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborating Sponsors:
University of Chicago
Mayo Clinic
Conditions:
Pulmonary Arterial Hypertension
Eligibility:
All Genders
18-100 years
Brief Summary
Develop a brief, new, patient reported outcome instrument that is valid for use in clinical practice and clinical trials.
Detailed Description
This study will use the Clinical Impact Method to develop a patient reported outcome for use in patients with pulmonary arterial hypertension Clinical personnel at the study sites will approach and di...
Eligibility Criteria
Inclusion
- Evidence of a personally signed and dated informed consent
- Subjects aged \>=18 who have documented PAH
- Speak English
- Subjects who provide written informed consent to participate in the study before being screened for the study.
Exclusion
- Patients with non-PAH Pulmonary Hypertension
- Physical inability to complete the interview process
- Subjects who are currently enrolled in an experimental drug study
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01792622
Start Date
July 1 2013
End Date
September 1 2013
Last Update
January 28 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.